BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14612511)

  • 1. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Sheard MA; Uldrijan S; Vojtesek B
    Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker HL; Koumenis C; Giaccia AJ
    Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
    Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.
    Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG
    Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
    Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation.
    Gutiérrez del Arroyo A; Gil-Lamagniere C; Lazaro I; de Marco MC; Layunta I; Silva A
    Oncogene; 2000 Jul; 19(32):3647-55. PubMed ID: 10951571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells.
    Unger C; Buchmann A; Bünemann CL; Kress S; Schwarz M
    Cell Death Differ; 1998 Jan; 5(1):87-95. PubMed ID: 10200449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated gamma-irradiation renders tumour cells more responsive to apoptotic signals through CD95.
    Sheard MA; Krammer PH; Zaloudik J
    Br J Cancer; 1999 Aug; 80(11):1689-96. PubMed ID: 10468284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.
    Zalcenstein A; Stambolsky P; Weisz L; Müller M; Wallach D; Goncharov TM; Krammer PH; Rotter V; Oren M
    Oncogene; 2003 Aug; 22(36):5667-76. PubMed ID: 12944915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation.
    Semont A; Nowak EB; Silva Lages C; Mathieu C; Mouthon MA; May E; Allemand I; Millet P; Boussin FD
    Oncogene; 2004 Nov; 23(52):8497-508. PubMed ID: 15361846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis.
    Rakkar AN; Katayose Y; Kim M; Craig C; Ohri E; Li Z; Cowan KH; Seth P
    Cell Death Differ; 1999 Apr; 6(4):326-33. PubMed ID: 10381625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
    Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
    Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
    Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.